Abstract Purpose of Review Obesity is a recognized risk factor for the development of breast
cancer and recurrence even when patients are treated appropriately. We reviewed the …

The emphasis in contemporary medical oncology has been “precision” or “personalized”
medicine, terms that imply a strategy to improve efficacy through targeted therapies. Similar …

The therapeutic options for patients with noninvasive or invasive breast cancer are complex
and varied. These NCCN Clinical Practice Guidelines for Breast Cancer include …

Background We previously reported the 5-year results of the phase 3 IBCSG 23-01 trial
comparing disease-free survival in patients with breast cancer with one or more …

Background: in current clinical practice, the standard evaluation for axillary lymph node
(ALN) status in breast cancer has a low efficiency and is based on an invasive procedure …

The International Symposium on Biomedical Imaging (ISBI) held a grand challenge to
evaluate computational systems for the automated detection of metastatic breast cancer in …

Abnormal H2O2 levels are closely related to many diseases, including inflammation and
cancers. Herein, we simultaneously load HRP and its substrate, 2, 2′-azino-bis (3 …

Ductal carcinoma in situ (DCIS) of the breast represents a heterogeneous group of
neoplastic lesions in the breast ducts. The goal for management of DCIS is to prevent the …

Background The optimum timing of sentinel-lymph-node biopsy for breast cancer patients
treated with neoadjuvant chemotherapy is uncertain. The SENTINA (SENTinel NeoAdjuvant) …

Sentinel Lymph Node Biopsy for Patients With Early-Stage Breast Cancer: American
Society of Clinical Oncology Clinical Practice Page 1 Sentinel Lymph Node Biopsy for …